Chemotherapy source book

Chemotherapy source book / editors, Michael C. Perry, associate editors, Donald C. Doll, Carl E. Freter.

Perry's The Chemotherapy Source Book, now in its fifth edition, provides information on the choice of chemotherapeutic agents, the use of combination chemotherapy, and the toxicity of individual drugs. Organized by site, this is the only book of its kind to focus strictly on the clinical practi...

Full description

Saved in:
Bibliographic Details
Other Authors: Perry, Michael C. (Michael Clinton), 1945-, Doll, Donald C., Freter, Carl E.
Format: eBook
Language:English
Published: Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, ©2012.
Edition:5th ed.
Subjects:
Cancer > Chemotherapy.
Antineoplastic agents.
Antimitotic agents.
MEDICAL > Internal Medicine.
Antimitotic agents
Antineoplastic agents
Cancer > Chemotherapy
Online Access:Click for online access
Table of Contents:
  • Scientific basis of cancer chemotherapy
  • Norton-Simon hypothesis
  • Drug resistance
  • Principles of chemotherapy
  • Clinical trials
  • Hematopoietic growth factors
  • Biologic response modifiers: principles of biotherapy
  • Intraventricular and intrathecal therapy
  • Intraperitoneal chemotherapy
  • Intraarterial chemotherapy
  • Hematopoietic stem cell transplantation
  • Oral toxicity
  • Dermatologic toxicity
  • Extravasation
  • Hypersensitivity reactions
  • Ocular side effects of cancer therapeutics
  • Cardiotoxicity of cancer therapy
  • Pulmonary toxicity of chemotherapeutic agents
  • Gastrointestinal complications of chemotherapy
  • Hepatotoxicity of chemotherapeutic agents
  • Chemotherapy-induced renal and electrolyte dysfunction
  • Chemotherapy-induced peripheral neuropathy
  • Vascular toxicity of antineoplastic agents
  • Second malignancies after chemotherapy
  • Chemotherapy in pregnancy
  • Gonadal complications and teratogenicity of cancer therapy
  • Central venous access for chemotherapy
  • Systemic therapy for advanced melanoma
  • Chemotherapy of primary brain tumors
  • Chemotherapy for head and neck cancer
  • Chemotherapy of lung cancer
  • Breast cancer
  • Gastrointestional cancer
  • Endocrine tumors
  • Chemotherapy of genitourinary cancer
  • Chemotherapy of gynecologic cancers
  • Chemotherapy of carcinoma of unknown primary site
  • Chemotherapy of bone and soft tissue sarcomas
  • Chemotherapy for pediatric solid tumors
  • Chemotherapy for childhood leukemia
  • Chemotherapy of Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
  • Myelodysplastic syndromes
  • Management of myeloproliferative disorders and chronic myeloid leukemia
  • Chemotherapy of multiple myeloma
  • Appendics: I: Chemotherapeutic agents
  • II: Chemotherapy programs
  • III: Common terminology criteria for adverse events (CTCAE) version 4.0.

Similar Items